Annals of agricultural and environmental medicine : AAEM · 2012
Replacement therapy of secondary hypothyroidism in children born with low body weight improves mental development.
Клиническое исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ben-Skowronek Iwona, Wisniowiecka Magdalena
Аннотация
BACKGROUND: Secondary hypothyroidism is observed in children after brain damage. The aim of the study was evaluation of the mental development in preterm-born children during replacement therapy with l-thyroxin because of secondary hypothyroidism.
MATERIALS AND METHODS: The motor and mental development of preterm newborns with secondary hypothyroidism treated with l-thyroxin since the second week of life were compared with the development of preterm newborns with secondary hypothyroidism treated since the fourth week, or later. Motor development was evaluated, and the mental development and IQ assessed by the Wechsler Intelligence Scale for Children in the seventh year of life.
RESULTS: Earlier achievement of the milestones of motor development, i.e. sitting, standing, and walking, was observed in children from the group who received early treatment with modest doses of l-thyroxin. In this group, all infants acquired the motor functions statistically significantly earlier in comparison to the infants from group with delayed treatment. In the seventh year of life, the IQs were significantly higher in group I treated since the second week of life, compared to group II.
CONCLUSIONS: The early replacement therapy with l-thyroxin initiated in the second week of life may improve long-term mental development in children.
MATERIALS AND METHODS: The motor and mental development of preterm newborns with secondary hypothyroidism treated with l-thyroxin since the second week of life were compared with the development of preterm newborns with secondary hypothyroidism treated since the fourth week, or later. Motor development was evaluated, and the mental development and IQ assessed by the Wechsler Intelligence Scale for Children in the seventh year of life.
RESULTS: Earlier achievement of the milestones of motor development, i.e. sitting, standing, and walking, was observed in children from the group who received early treatment with modest doses of l-thyroxin. In this group, all infants acquired the motor functions statistically significantly earlier in comparison to the infants from group with delayed treatment. In the seventh year of life, the IQs were significantly higher in group I treated since the second week of life, compared to group II.
CONCLUSIONS: The early replacement therapy with l-thyroxin initiated in the second week of life may improve long-term mental development in children.